PUBLISHER: The Business Research Company | PRODUCT CODE: 1938968
PUBLISHER: The Business Research Company | PRODUCT CODE: 1938968
Intravascular catheterization refers to the process of inserting a catheter into a blood vessel to enable the delivery of medications or fluids, or for monitoring vital physiological parameters. This procedure is widely used in clinical settings to ensure direct access to the bloodstream for therapeutic or diagnostic purposes.
The primary types of intravascular catheterization include centrally inserted catheters, peripherally inserted central catheters (PICC), peripheral catheters, and dialysis catheters. Centrally inserted catheters are designed for long-term use and are placed into major central veins, such as the subclavian or jugular veins. These catheters are manufactured using various materials, including polyurethane, silicone, polyvinyl chloride (PVC), and others, and are utilized in diverse procedures including elective surgeries, emergency care, interventional radiology, and cardiac interventions. Their applications span across fields such as oncology, cardiology, pediatrics, and infection control, serving end users including hospitals, ambulatory surgical centers (ASCs), home healthcare providers, and research laboratories.
Tariffs are impacting the intravascular catheterization market by increasing costs of imported medical-grade polymers, tubing materials, connectors, and precision manufacturing equipment used in catheter production. Hospitals and healthcare providers in North America and Europe are most affected due to reliance on imported raw materials, while Asia-Pacific faces pricing pressure on catheter exports. These tariffs are contributing to higher supply costs and procurement challenges. However, they are also encouraging domestic manufacturing, regional material sourcing, and innovation in cost-efficient catheter technologies.
The intravascular catheterization market research report is one of a series of new reports from The Business Research Company that provides intravascular catheterization market statistics, including intravascular catheterization industry global market size, regional shares, competitors with a intravascular catheterization market share, detailed intravascular catheterization market segments, market trends and opportunities, and any further data you may need to thrive in the intravascular catheterization industry. This intravascular catheterization market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The intravascular catheterization market size has grown strongly in recent years. It will grow from $13.54 billion in 2025 to $14.48 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to increasing hospital-based intravenous therapies, rising use of catheters in critical care, advancements in catheter materials, growing prevalence of chronic diseases, improved vascular access techniques.
The intravascular catheterization market size is expected to see strong growth in the next few years. It will grow to $18.83 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increasing demand for minimally invasive vascular access, rising focus on reducing catheter-related infections, expansion of outpatient and home-based care, technological advancements in catheter design, growing use of smart monitoring catheters. Major trends in the forecast period include increasing use of advanced central and peripheral catheters, rising demand for infection-resistant materials, growing adoption of long-term vascular access solutions, expansion of image-guided catheter placement, enhanced focus on patient safety and comfort.
The growing incidence of cardiovascular disorders is expected to drive the expansion of the intravascular catheterization market in the coming years. Cardiovascular disorders include a wide range of conditions affecting the heart and blood vessels, such as heart disease, stroke, and hypertension. The increasing prevalence of these disorders is largely associated with rising obesity rates, which contribute to major risk factors including high blood pressure and diabetes, both of which significantly elevate the risk of heart disease. Intravascular catheterization plays a critical role in managing cardiovascular conditions by enabling minimally invasive procedures used to diagnose and treat coronary artery disease, perform angioplasty, and deploy stents to restore and improve blood flow. For example, in October 2025, according to the Centers for Disease Control and Prevention, a US-based government agency, 919,032 deaths in the United States in 2023 were attributed to cardiovascular disease, accounting for approximately one in every three deaths. Additionally, around 805,000 individuals in the country experience a heart attack each year. Therefore, the rising incidence of cardiovascular disorders is contributing to the growth of the intravascular catheterization market.
Major companies operating in the intravascular catheterization market are concentrating on the development of advanced technologies, such as artificial intelligence (AI)-enabled intravascular ultrasound (IVUS) systems, to improve imaging accuracy and optimize clinical workflows. AI-powered IVUS systems integrate conventional intravascular ultrasound technology with AI algorithms to enhance image precision, increase efficiency, and improve interpretation during cardiovascular interventions. For instance, in October 2023, Evident Vascular Inc., a US-based medical technology company, introduced an AI-enabled IVUS platform designed to generate high-resolution images from within blood vessels to evaluate vascular disease and support interventional procedures. This next-generation catheter-based ultrasound system utilizes artificial intelligence to improve image quality, assist clinical interpretation, and streamline workflows, initially targeting peripheral vascular interventions with planned expansion into coronary applications.
In April 2025, Boston Scientific Corporation, a US-based supplier of minimally invasive cardiovascular devices, acquired Bolt Medical for US$443 million. Through this acquisition, Boston Scientific seeks to broaden its cardiovascular product portfolio by incorporating a complementary next-generation intravascular lithotripsy technology, strengthening its ability to treat complex calcified arterial disease and reinforcing its position in minimally invasive interventional cardiology solutions. Bolt Medical is a US-based medical technology company specializing in the development of innovative laser-based intravascular lithotripsy catheters.
Major companies operating in the intravascular catheterization market are Cardinal Health Inc., Johnson & Johnson (C. R. Bard), Medtronic plc, Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Edwards Lifesciences Corporation, Nipro Corporation, Teleflex Incorporated, Cook Medical LLC, ICU Medical Inc., Smiths Medical, Merit Medical Systems Inc., Vygon SA, AngioDynamics Inc., ACIST Medical Systems Inc., Shanghai Kindly Enterprise Development Group Co. Ltd., Fresenius Medical Care AG & Co. KGaA, Medline Industries Inc., Argon Medical Devices Inc., Rex Medical LP, Galt Medical Corp., Poly Medicure Ltd.
North America was the largest region in the intravascular catheterization market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravascular catheterization market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the intravascular catheterization market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The intravascular catheterization market includes revenues earned by entities by providing services such as coronary angiography, percutaneous coronary intervention, dialysis catheter insertion, and neurological applications. The market value includes the value of related goods sold by the service provider or included within the service offering. The intravascular catheterization market also consists of sales of vascular access catheters, guiding catheters, introducer sheaths, hemodialysis catheters, and balloon catheters. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Intravascular Catheterization Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses intravascular catheterization market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for intravascular catheterization ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The intravascular catheterization market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.